Genetic Technologies (GENE) Competitors $0.76 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends GENE vs. TSBX, EYEN, SNSE, BLRX, BCLI, BGXX, WENA, AWH, SPRC, and KPRXShould you be buying Genetic Technologies stock or one of its competitors? The main competitors of Genetic Technologies include Turnstone Biologics (TSBX), Eyenovia (EYEN), Sensei Biotherapeutics (SNSE), BioLineRx (BLRX), Brainstorm Cell Therapeutics (BCLI), Bright Green (BGXX), ANEW Medical (WENA), Aspira Women's Health (AWH), SciSparc (SPRC), and Kiora Pharmaceuticals (KPRX). These companies are all part of the "pharmaceutical products" industry. Genetic Technologies vs. Turnstone Biologics Eyenovia Sensei Biotherapeutics BioLineRx Brainstorm Cell Therapeutics Bright Green ANEW Medical Aspira Women's Health SciSparc Kiora Pharmaceuticals Genetic Technologies (NASDAQ:GENE) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Does the MarketBeat Community favor GENE or TSBX? Genetic Technologies received 157 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 55.33% of users gave Genetic Technologies an outperform vote while only 50.00% of users gave Turnstone Biologics an outperform vote. CompanyUnderperformOutperformGenetic TechnologiesOutperform Votes16155.33% Underperform Votes13044.67% Turnstone BiologicsOutperform Votes450.00% Underperform Votes450.00% Is GENE or TSBX more profitable? Genetic Technologies' return on equity of 0.00% beat Turnstone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Genetic TechnologiesN/A N/A N/A Turnstone Biologics N/A -105.99%-87.27% Does the media prefer GENE or TSBX? In the previous week, Genetic Technologies had 9 more articles in the media than Turnstone Biologics. MarketBeat recorded 10 mentions for Genetic Technologies and 1 mentions for Turnstone Biologics. Turnstone Biologics' average media sentiment score of 0.00 beat Genetic Technologies' score of -0.06 indicating that Turnstone Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genetic Technologies 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Turnstone Biologics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, GENE or TSBX? Genetic Technologies has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500. Which has stronger earnings & valuation, GENE or TSBX? Genetic Technologies has higher earnings, but lower revenue than Turnstone Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenetic Technologies$7.66M0.44-$7.88MN/AN/ATurnstone Biologics$19.31M0.53-$55.20M-$3.24-0.14 Do insiders and institutionals believe in GENE or TSBX? 0.6% of Genetic Technologies shares are owned by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are owned by institutional investors. 6.5% of Genetic Technologies shares are owned by company insiders. Comparatively, 32.1% of Turnstone Biologics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer GENE or TSBX? Turnstone Biologics has a consensus target price of $2.13, indicating a potential upside of 381.86%. Given Turnstone Biologics' stronger consensus rating and higher possible upside, analysts clearly believe Turnstone Biologics is more favorable than Genetic Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genetic Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Turnstone Biologics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTurnstone Biologics beats Genetic Technologies on 9 of the 15 factors compared between the two stocks. Get Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENE vs. The Competition Export to ExcelMetricGenetic TechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.37M$2.96B$5.24B$8.95BDividend YieldN/A1.94%5.13%4.04%P/E RatioN/A45.5689.3017.34Price / Sales0.44265.291,255.2478.66Price / CashN/A192.9043.8235.97Price / Book3.063.965.324.79Net Income-$7.88M-$41.02M$122.69M$225.00M7 Day PerformanceN/A-1.74%-0.16%1.52%1 Month PerformanceN/A0.53%3.75%4.68%1 Year Performance-58.65%-1.69%27.41%20.89% Genetic Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050News CoverageHigh Trading VolumeTSBXTurnstone Biologics3.0271 of 5 stars$0.58+9.4%$2.13+266.6%-77.6%$13.41M$19.31M-0.1882High Trading VolumeEYENEyenovia2.4089 of 5 stars$0.12+6.9%$2.00+1,599.2%-96.0%$13.12M$31,832.00-0.1640Short Interest ↑News CoverageGap UpSNSESensei Biotherapeutics4.3911 of 5 stars$0.52+3.2%$4.33+731.7%-33.8%$13.10MN/A-0.4440Short Interest ↑News CoverageGap DownBLRXBioLineRx2.9298 of 5 stars$0.16-40.3%$9.00+5,408.0%-92.6%$13.06M$21.99M-0.7440Stock SplitNews CoverageGap DownBCLIBrainstorm Cell Therapeutics4.3866 of 5 stars$2.26+1.3%$30.00+1,227.4%-61.4%$12.89MN/A-0.4740Short Interest ↓BGXXBright GreenN/A$0.07+7.7%N/A-68.1%$12.64MN/A-1.102Gap DownWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpAWHAspira Women's Health2.417 of 5 stars$0.74+2.8%$4.40+494.6%-89.4%$12.33M$8.96M-0.62110Short Interest ↓Positive NewsGap DownSPRCSciSparc0.6017 of 5 stars$1.13+114.1%N/A-82.9%$11.70M$1.75M0.004Gap DownHigh Trading VolumeKPRXKiora Pharmaceuticals3.9132 of 5 stars$3.86+6.3%$10.00+159.1%-19.8%$11.58M$16M0.0010Short Interest ↓Positive NewsGap Up Related Companies and Tools Related Companies TSBX Alternatives EYEN Alternatives SNSE Alternatives BLRX Alternatives BCLI Alternatives BGXX Alternatives WENA Alternatives AWH Alternatives SPRC Alternatives KPRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GENE) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENE Stock Alerts